RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic Stroke "RELAXED"


Phase N/A Results N/A

Summary of Purpose

Early recurrence of cardioembolic stroke in patients with atrial fibrillation is common, reaching approximately 6% within 30 days after initial stroke. Therefore, it is preferable to provide early anticoagulation for cardioembolic stroke. However, early anticoagulation may increase the risk of hemorrhagic transformation of cerebral infarcts. It is difficult to decide the timing of initiation for anticoagulant...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 May 2014.

1 Feb 2014 1 May 2014 1 May 2016 1 May 2016 1 Apr 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample